GSA Capital Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$216K Buy
2025
Q1
$160K Buy
2022
Q1
Sell
2021
Q4
$127K Buy
2020
Q3
Sell
2020
Q2
$163K Buy
2020
Q1
Sell
2019
Q4
$155K Sell
2019
Q3
$147K Buy
2016
Q4
Sell
2016
Q3
$705K Buy
2016
Q2
$221K Sell
2016
Q1
$376K Buy
2015
Q3
Sell
2015
Q2
$476K Buy
2014
Q3
Sell
2014
Q2
$228K Buy